A detailed history of Tsfg, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Tsfg, LLC holds 94,225 shares of ABT stock, worth $10.7 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares
94,225
Previous 96,047 1.9%
Holding current value
$10.7 Million
Previous $9.98 Million 7.65%
% of portfolio
2.35%
Previous 2.33%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$100.07 - $118.13 $182,327 - $215,232
-1,822 Reduced 1.9%
94,225 $10.7 Million
Q2 2024

Jul 16, 2024

BUY
$100.73 - $112.44 $584,939 - $652,939
5,807 Added 6.44%
96,047 $9.98 Million
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $985,570 - $1.09 Million
-8,999 Reduced 9.07%
90,240 $10.3 Million
Q4 2023

Jan 23, 2024

BUY
$90.19 - $110.4 $272,914 - $334,070
3,026 Added 3.15%
99,239 $10.9 Million
Q3 2023

Oct 10, 2023

BUY
$95.53 - $114.62 $450,423 - $540,433
4,715 Added 5.15%
96,213 $9.32 Million
Q2 2023

Jul 10, 2023

SELL
$100.78 - $112.29 $126,277 - $140,699
-1,253 Reduced 1.35%
91,498 $9.98 Million
Q1 2023

Apr 21, 2023

BUY
$96.86 - $114.01 $129,695 - $152,659
1,339 Added 1.46%
92,751 $9.39 Million
Q4 2022

Jan 19, 2023

BUY
$95.06 - $111.52 $233,372 - $273,781
2,455 Added 2.76%
91,412 $10 Million
Q3 2022

Oct 20, 2022

BUY
$96.76 - $112.03 $496,378 - $574,713
5,130 Added 6.12%
88,957 $8.61 Million
Q2 2022

Jul 13, 2022

SELL
$102.07 - $123.37 $24,394 - $29,485
-239 Reduced 0.28%
83,827 $9.11 Million
Q1 2022

Apr 25, 2022

SELL
$114.02 - $139.04 $145,945 - $177,971
-1,280 Reduced 1.5%
84,066 $9.95 Million
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $909,914 - $1.11 Million
7,876 Added 10.17%
85,346 $12 Million
Q3 2021

Oct 12, 2021

BUY
$116.66 - $129.06 $339,597 - $375,693
2,911 Added 3.9%
77,470 $9.15 Million
Q2 2021

Jul 19, 2021

BUY
$105.79 - $124.53 $275,159 - $323,902
2,601 Added 3.61%
74,559 $8.64 Million
Q1 2021

Apr 14, 2021

BUY
$108.84 - $128.23 $200,918 - $236,712
1,846 Added 2.63%
71,958 $8.62 Million
Q4 2020

Jan 20, 2021

BUY
$105.0 - $114.42 $6,405 - $6,979
61 Added 0.09%
70,112 $7.68 Million
Q3 2020

Oct 06, 2020

BUY
$91.64 - $111.29 $1.69 Million - $2.06 Million
18,496 Added 35.88%
70,051 $7.62 Million
Q2 2020

Jul 07, 2020

BUY
$76.57 - $98.0 $328,638 - $420,616
4,292 Added 9.08%
51,555 $4.71 Million
Q1 2020

Apr 08, 2020

BUY
$62.82 - $91.86 $284,134 - $415,482
4,523 Added 10.58%
47,263 $3.73 Million
Q4 2019

Jan 27, 2020

BUY
$78.51 - $87.4 $300,222 - $334,217
3,824 Added 9.83%
42,740 $3.71 Million
Q3 2019

Jan 27, 2020

BUY
$81.84 - $88.74 $796,303 - $863,440
9,730 Added 33.34%
38,916 $3.26 Million
Q2 2019

Jan 27, 2020

BUY
$72.88 - $85.0 $422,558 - $492,830
5,798 Added 24.79%
29,186 $2.45 Million
Q1 2019

Jan 27, 2020

BUY
$66.22 - $80.06 $1.55 Million - $1.87 Million
23,388 New
23,388 $1.87 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tsfg, LLC Portfolio

Follow Tsfg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.